A detailed history of Cetera Trust Company, N.A transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Cetera Trust Company, N.A holds 2,190 shares of NBIX stock, worth $273,750. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,190
Previous 2,190 -0.0%
Holding current value
$273,750
Previous $301 Million 16.31%
% of portfolio
0.15%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$130.4 - $143.74 $16,300 - $17,967
-125 Reduced 5.4%
2,190 $302 Million
Q4 2023

Feb 01, 2024

BUY
$106.07 - $132.76 $245,552 - $307,339
2,315 New
2,315 $305 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Cetera Trust Company, N.A Portfolio

Follow Cetera Trust Company, N.A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Trust Company, N.A, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Trust Company, N.A with notifications on news.